With the Protecting Access to Medicare Act (PAMA) appropriate use criteria (AUC) program paused, healthcare providers may be unsure if they should continue using AUC and Clinical Decision Support (CDS). While providers that have already implemented CDS are urged to continue their use during the pause, questions may linger.
If you have questions about PAMA, AUC or CDS, then join the American College of Radiology®, March 20, 3–4pm ET for the Appropriateness Criteria and Clinical Decision Support: Good for Patients, Providers and Healthcare Facilities webinar.
ACR Presents to FDA on Oversight Considerations for GenAI Medical Devices
The ACR® presented at the U.S. FDA Digital Health Advisory Committee meeting “Total Product Lifecycle Considerations for Generative AI-Enabled Devices.” Bernardo Bizzo, MD, PhD, ACR Data Science Institute® Associate Chief Science Officer, represented the College at the meeting.
Read moreACR DSI Releases 2 New Non-Interpretive Reading Room Use Cases
use cases, artificial intelligence, reading room
Read moreDirect Supervision for Contrast Studies
We recommend that sites follow the ACR CT and MR Accreditation requirements for onsite supervision of contrast administration and management.
Read more